Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Polvino, William"'
Autor:
Garcia, José M., Polvino, William J.
Publikováno v:
In Growth Hormone & IGF Research 2009 19(3):267-273
Publikováno v:
In Peptides 2005 26(9):1598-1601
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hill, Albert F.1 HILLSDEN1@AOL.COM, Polvino, William J.2 wpolvino@rejuvenon.com, Wilson, Darcy B.3 dbwilson@tpims.org
Publikováno v:
Journal of Immune Based Therapies & Vaccines. 2005, Vol. 3, p5-12. 12p. 5 Graphs.
Autor:
Taylor, Addison A *, Shepherd, Alexander M, Polvino, William, Mangoo-Karim, Roberto, Ballard, Kevin, Sunthornyothin, Sarat, Luther, Robert R, Pool, James L
Publikováno v:
In American Journal of Hypertension 1999 12(9):906-914
Autor:
Gail Murphy, John-Olov Jansson, Claes Ohlsson, Subburaman Mohan, D. Wyss, Johan Svensson, Barry J. Gertz, K. Cerchio, D Krupa, Bengt-Åke Bengtsson, Polvino William J, David J. Baylink
Publikováno v:
Journal of Bone and Mineral Research. 13:1158-1166
The effect of 2 months of treatment with the oral growth hormone (GH) secretagogue MK-677 on markers of bone metabolism was determined in healthy obese male subjects. This was a randomized, double-blind, parallel, placebo-controlled study. Twenty-fou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a726910318fb39c355d4788a7f5087e6
https://doi.org/10.1359/jbmr.1998.13.7.1158
https://doi.org/10.1359/jbmr.1998.13.7.1158
Autor:
Johan Svensson, D Krupa, Polvino William J, K. Cerchio, Lars Lönn, John-Olov Jansson, Barry J. Gertz, Gail Murphy, B.-Å. Bengtsson, I. Boseaus, D. Wyss, Lars Sjöström
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 83:362-369
Obesity is associated with blunted GH secretion, unfavorable body composition, and increased cardiovascular mortality. The objective of this study was to investigate the effects of oral treatment with the GH secretagogue MK-677 on GH secretion and bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b06a7a3f878e16a934543d502536e11
https://doi.org/10.1210/jcem.83.2.4539
https://doi.org/10.1210/jcem.83.2.4539
Autor:
K. Cerchio, Polvino William J, D Krupa, Ora H. Pescovitz, Michael O. Thorner, Barry J. Gertz, Gail Murphy, Emily H. Skiles, Theresa Treep, Suzan S. Pezzoli, Ian Chapman
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 82:3455-3463
To determine the effect of the GH releasing peptide (GHRP)-mimetic, MK-677, on the GH/insulin-like growth factor-I (IGF-I) axis in selected GH-deficient adults, we studied nine severely GH-deficient men [peak serum GH concentration in response to ins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a642c5dd40302400056ab0a3475e9bc0
https://doi.org/10.1210/jcem.82.10.4297
https://doi.org/10.1210/jcem.82.10.4297
Autor:
Donald B. Kimmel, Henry G. Bone, Angelo A. Licata, Barry J. Gertz, Polvino William J, Robert S. Weinstein, Joseph R. Tucci, Michael R. McClung, Erika Hale, Steven T. Harris, Robert W. Downs
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 82:265-274
Alendronate (ALN) is an aminobisphosphonate employed as an antiresorptive agent in the treatment of osteoporosis. The present study was carried out to determine dose-response relationships, particularly the effects of relatively low doses of ALN, on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f934feb9ebf4d1bfe3b7a8efc594cba
https://doi.org/10.1210/jcem.82.1.3682
https://doi.org/10.1210/jcem.82.1.3682
Autor:
Timothy Mant, Timothy V Olah, Michael Stepanavage, Johanna Wittreich, Haiyung Cheng, Barry J. Gertz, Mark Edwards, David G. Sciberras, Polvino William J
Publikováno v:
British Journal of Clinical Pharmacology. 43:49-54
Aim We evaluated the pharmacokinetics and pharmacodynamics of oral MK-462 in comparison with oral sumatriptan in healthy male volunteers. Methods Sixteen healthy male volunteers were studied in a rising, single dose, alternating panel design with eig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b07c0b17489e7ecde50bc26a4b8a13ef
https://doi.org/10.1111/j.1365-2125.1997.tb00137.x
https://doi.org/10.1111/j.1365-2125.1997.tb00137.x